VBI VACCINES INC's ticker is VBIV and the CUSIP is 91822J103. A total of 70 filers reported holding VBI VACCINES INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $7,996 | +79860.0% | 26,390 | +0.3% | 0.00% | – |
| Q4 2022 | $10 | -99.9% | 26,300 | 0.0% | 0.00% | – |
| Q3 2022 | $19,000 | -9.5% | 26,300 | -1.0% | 0.00% | – |
| Q2 2022 | $21,000 | -62.5% | 26,565 | -20.9% | 0.00% | – |
| Q1 2022 | $56,000 | -29.1% | 33,565 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $79,000 | -21.8% | 33,565 | +3.1% | 0.00% | 0.0% |
| Q3 2021 | $101,000 | -11.4% | 32,565 | -4.4% | 0.00% | 0.0% |
| Q2 2021 | $114,000 | -8.1% | 34,065 | -14.5% | 0.00% | 0.0% |
| Q1 2021 | $124,000 | +21.6% | 39,850 | -15.4% | 0.00% | 0.0% |
| Q4 2020 | $102,000 | +2.0% | 47,100 | +34.8% | 0.00% | 0.0% |
| Q3 2020 | $100,000 | +51.5% | 34,950 | +64.9% | 0.00% | 0.0% |
| Q2 2020 | $66,000 | +1220.0% | 21,200 | +92.7% | 0.00% | – |
| Q3 2019 | $5,000 | – | 11,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 52,335,002 | $86,876,000 | 1.74% |
| GENERAL AMERICAN INVESTORS CO INC | 1,877,497 | $3,117,000 | 0.25% |
| Newbridge Financial Services Group, Inc. | 172,969 | $287,000 | 0.14% |
| Virtus ETF Advisers LLC | 69,220 | $115,000 | 0.05% |
| ArchPoint Investors | 65,000 | $108,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 115,365 | $192,000 | 0.03% |
| GRIMES & COMPANY, INC. | 281,077 | $467,000 | 0.02% |
| Cambridge Investment Research Advisors, Inc. | 2,189,700 | $3,635,000 | 0.02% |
| WEALTHSOURCE PARTNERS, LLC | 143,500 | $238,000 | 0.02% |
| CARDIFF PARK ADVISORS, LLC | 64,100 | $106,000 | 0.02% |